SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, IoT and cybersecurity sectors, has announced results for the three months ended March 31, 2024. Among the highlights, the company reported an 8% increase in revenue to $6.9 million from $6.4 million and 139% increase in gross profit to $3.8 million from $1.6…
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical solutions, has announced a new member of its board of directors. According to the announcement, Sergei Glinka, a seasoned and highly respected business executive, will serve on the board. An Estonian citizen, Glinka has served in several executive and board roles positions in large European companies, including…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting its full-year financial results for 2023 along with a company update. Highlights of the report included news that, in the first…
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced record financial results for the first fiscal quarter ended March 31, 2024, which includes the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD). “First quarter results continued to demonstrate the fundamental strength of…
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received a $100 million financing commitment from a family office; the company has also sold up to an additional $50 million of senior secured convertible notes to family offices and high net worth investors. According to the announcement, this $150 million capital infusion allows Mullen…
Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, acquires value-add real estate within the regulated U.S. cannabis industry with selective development innovation and aspirations to spearhead direct-to-consumer real estate leased to best-in-class cannabis retailers. “The aptly named company has a deep understanding of all the hurdles and potholes…
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions for automotive and smart infrastructure applications, has entered a contract with Koito Manufacturing to jump-start the execution of a new original equipment manufacturing (“OEM”) program, which the two companies have secured. The two companies have worked together as tier 1 partners, and Koito is…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, on Thursday reported its financial results for the full year 2023, which ended on Dec. 31, 2023. Among other highlights,…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R) products, is reporting its financial and operational results for first quarter 2024. Highlights of the report include record quarterly revenues of $415,000, up 78% from Q1 2023; Evolve(TM) becoming the company’s best-selling product,…
Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly owned subsidiary, AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market. “During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost, resulting in reduced profits. AgLAB’s Maximum Value Processing (‘MVP’)…
SenesTech (NASDAQ: SNES), a rodent fertility control solutions provider, recently announced multiple distribution deals globally in what marks a huge milestone for the company. “These deals bring YTD 2024 total revenue up more than 80% compared to YTD 2023. SenesTech also announced its foray into the European market with its distribution agreement with Q-chem, a…
Bravo (OTC: BRVO) is a company actively exploring opportunities in the entertainment, hospitality and technology sectors to generate long-term value through high-growth business ventures. “Bravo is currently focused on pioneering innovative solutions in the digital content landscape, with a goal of providing cutting-edge and diverse content experiences to global audiences. In February 2024, Bravo finalized…
Correlate (OTCQB: CIPI) is a distributed energy solutions company focused on solar energy installation opportunities as well as other clean energy infrastructure improvements. As federal government incentives and decreasing costs of solar installation help to scale clean energy adoption across the United States, CIPI is positioned for growth. “We have a constant conveyor belt of…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed);…
SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, IoT and cybersecurity sectors, will hold a conference call at 10 a.m. Eastern Time on Wednesday, May 15, 2024, to discuss its financial results for the first quarter ended March 31, 2024. According to the announcement, financial results will be issued in a…
Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “When we designed Sigyn Therapy, we envisioned a medical device that could overcome the limitations of previous blood purification technologies to treat…
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today announced that it has received a staff determination letter on April 30, 2024, from the Listing Qualifications Department of the Nasdaq Stock Market LLC. In…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be releasing its first-quarter 2024 financial results this month. The company announced that it will release the report, along with a business update, on May 14,…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced the launch of Evolve(TM) Mouse. Evolve Mouse utilizes a breakthrough fertility solution to control mouse infestations. It is designated as a ‘minimum’ risk product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the…